A share price of Tarsus Pharmaceuticals Inc [TARS] is currently trading at $54.03, up 4.52%. An important factor to consider is whether the stock is rising or falling in short-term value. The TARS shares have gain 4.15% over the last week, with a monthly amount glided 0.61%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On November 20, 2023, Goldman initiated with a Neutral rating and assigned a price target of $19 on the stock. William Blair started tracking the stock assigning a Outperform rating and suggested a price target of $44 on July 18, 2023. Guggenheim initiated its recommendation with a Buy. Barclays started tracking with a Overweight rating for this stock on August 01, 2022, and assigned it a price target of $40. In a note dated December 21, 2021, H.C. Wainwright initiated an Buy rating and provided a target price of $40 on this stock.
Tarsus Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $31.05 and $59.76. Currently, Wall Street analysts expect the stock to reach $84 within the next 12 months. Tarsus Pharmaceuticals Inc [NASDAQ: TARS] shares were valued at $54.03 at the most recent close of the market. An investor can expect a potential return of 55.47% based on the average TARS price forecast.
Analyzing the TARS fundamentals
Trailing Twelve Months sales for Tarsus Pharmaceuticals Inc [NASDAQ:TARS] were 295.52M which represents 151.54% growth. Gross Profit Margin for this corporation currently stands at 0.93% with Operating Profit Margin at -0.33%, Pretax Profit Margin comes in at -0.31%, and Net Profit Margin reading is -0.31%. To continue investigating profitability, this company’s Return on Assets is posted at -0.19, Equity is -0.32 and Total Capital is -0.24. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Tarsus Pharmaceuticals Inc [NASDAQ:TARS] is 5.26. On the other hand, the Quick Ratio is 5.21, and the Cash Ratio is 1.07. Considering the valuation of this stock, the price to sales ratio is 7.72, the price to book ratio is 6.86.
Transactions by insiders
Recent insider trading involved LINK WILLIAM J PHD, Director, that happened on Sep 08 ’25 when 27116.0 shares were sold. Director, LINK WILLIAM J PHD completed a deal on Sep 08 ’25 to buy 27116.0 shares. Meanwhile, President/CEO and Board Chair Azamian Bobak R. sold 6000.0 shares on Aug 11 ’25.
